Status: Not yet recruiting
Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients
The study is designed to diminish intra-dialytic hypertension in chrnic hemodialysis patients suffering from metabolic acidosis (low bicarbonate levels). The intervention is a tab of 500 mg sodium bicarbonate twice a day for one month, vs. placebo.
Participants needed: 40
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Assaf-Harofeh Medical CenterUpdated: Nov 17, 2025Locations: 1
Eligibility criteria
Chronic hemodialysis patient > 3 months [+4]
age under 18, [+7]